Issued 2026-09-16 at $6.51 · now $6.51 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, VISN has typically landed between $4.69 and $9.24 — a range of −28.0% to +41.9% from the issuance price $6.51.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
3,219 overlapping 1 month windows · 2013-10-25 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($6.51) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where VISN has typically landed a month from the 2026-09-16 close of $6.51 — the range is history, not a prediction.
- now $6.51 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $6.43 (-1.3%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $5.52–$7.33
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $4.69–$9.24
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2020-02-18 | −60.2% | −60.2% | +0.1% |
| 2023-10-02 | −57.0% | −57.0% | +0.0% |
| 2024-02-01 | −56.7% | −56.7% | +0.9% |
| 3 best | |||
| 2024-07-22 | +153.5% | −4.6% | +153.5% |
| 2024-07-24 | +144.7% | +0.0% | +165.8% |
| 2024-07-25 | +142.5% | +0.0% | +143.6% |
3,219 overlapping windows · 2013-10-25 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~13 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 | KRAUSE L WILLIAM | director | Sale | 23,864 @ $6.27 | $150K | −24.3% of holding | not yet — horizon still open | not yet — horizon still open | 74,507 | Form 4 · filed 2 days after the trade |
| 2026-08-28 | KRAUSE L WILLIAM | director | Sale | 176,136 @ $6.75 | $1.2M | −64.2% of holding | not yet — horizon still open | not yet — horizon still open | 98,371 | Form 4 · filed 4 days after the trade |
| 2026-08-10 | Gilstrap Charles A | officer | Purchase | 10,000 @ $10.75 | $108K | +3.4% of holding | −42.5% | not yet — horizon still open | 302,417 | Form 4 · filed 2 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
24 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-10 | KRAUSE L WILLIAM | director | Gift | 102,300 | 274,507 | Form 4 |
| 2026-06-01 | Treadway Charles L. | director | Withheld for tax | 647,157 | 5,906,423 | Form 4 |
| 2026-06-01 | Watts Claudius E. IV | director | Withheld for tax | 168,746 | 1,347,729 | Form 4 |
| 2026-06-01 | Giordano Bartolomeo | officer | Withheld for tax | 100,442 | 464,479 | Form 4 |
| 2026-06-01 | Treadway Charles L. | director | Award / grant | 407,500 | 6,553,580 | Form 4 |
| 2026-06-01 | Watts Claudius E. IV | director | Award / grant | 53,000 | 1,516,475 | Form 4 |
| 2026-06-01 | Giordano Bartolomeo | officer | Award / grant | 16,300 | 564,921 | Form 4 |
| 2026-06-01 | Bowen Krista R. | officer | Award / grant | 48,900 | 407,454 | Form 4 |
| 2026-06-01 | Lorentzen Kyle David | officer | Award / grant | 159,000 | 2,214,307 | Form 4 |
| 2026-06-01 | Sucharczuk Guy | officer | Award / grant | 48,900 | 742,663 | Form 4 |
| 2026-06-01 | Gilstrap Charles A | officer | Award / grant | 16,300 | 292,417 | Form 4 |
| 2026-05-07 | GRAY STEPHEN C | director | Award / grant | 16,807 | 177,555 | Form 4 |
| 2026-05-07 | KRAUSE L WILLIAM | director | Award / grant | 16,807 | 376,807 | Form 4 |
| 2026-05-07 | Manning Tom | director | Award / grant | 16,807 | 177,797 | Form 4 |
| 2026-05-07 | Maguire Joanne M | director | Award / grant | 16,807 | 175,300 | Form 4 |
| 2026-05-07 | Roman Derrick A. | director | Award / grant | 16,807 | 139,909 | Form 4 |
| 2026-05-07 | Yates Timothy T | director | Award / grant | 16,807 | 58,807 | Form 4 |
| 2026-02-24 | Gilstrap Charles A | officer | Award / grant | 677 | 276,117 | Form 4 |
| 2026-02-24 | Giordano Bartolomeo | officer | Award / grant | 2,184 | 548,621 | Form 4 |
| 2026-02-24 | Lorentzen Kyle David | officer | Award / grant | 5,181 | 2,055,307 | Form 4 |
| 2026-02-24 | Bowen Krista R. | officer | Award / grant | 757 | 358,554 | Form 4 |
| 2026-02-24 | Watts Claudius E. IV | director | Award / grant | 2,365 | 1,463,475 | Form 4 |
| 2026-02-24 | Sucharczuk Guy | officer | Award / grant | 2,184 | 693,763 | Form 4 |
| 2026-02-24 | Treadway Charles L. | director | Award / grant | 18,171 | 6,146,080 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.